As Seagen Matures, CEO Siegall Talks About Moving The Growth Goalposts

 
• By Jessica Merrill

The ADC specialist could have a fourth cancer drug on the market this year and is preparing for its first commercial launch in Europe.

Glow up arrows circuit on dark blue background
Seagen expects to drive growth through new launches • Source: Shutterstock

More from Anticancer

More from Therapy Areas